APPRAISE: Atropine for Pain and Posterior Synechiae Reduction After Eye Surgery
This study, called APPRAISE, is looking at whether atropine 1% eyedrops are helpful after certain eye surgeries. Atropine eyedrops are often used after these surgeries, and this study will compare outcomes in patients who either use or don't use them. The main goal is to see how much pain you experience, measured by a pain score (Visual Analog Scale or VAS) one month after surgery. You might be able to join if you are having vitrectomy surgery, are 18 or older, and can give informed consent. You cannot join if you have an allergy to atropine or are using certain other eyedrops. The current status of this study is unclear, and it plans to enroll 62 participants.
- Study design
- This is an interventional study comparing outcomes in patients who either use or don't use atropine eyedrops after surgery. It plans to enroll 62 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your pain score will be measured one month after surgery.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
APPRAISE: Assessment of Pain and Posterior Synechiae Reduction With Atropine, an Investigation of Post-Surgical Eyes
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Jay Stewart, MD · PRINCIPAL_INVESTIGATOR · University of California, San Francisco
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Pain score on the Visual Analog Scale (VAS)1 month
Whether atropine use impacts post-operative pain score on the standard Visual Analog Scale (VAS)